Research programme: peptide tyrosine-tyrosine analogues - Carmot Therapeutics
Alternative Names: PYYLatest Information Update: 01 Feb 2024
At a glance
- Originator Carmot Therapeutics
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified